Head-to-Head

Bioventus Inc. Class A Common Stock vs. Stryker Corporation

BVS

Bioventus Inc. Class A Common Stock

$13.31 +3.10%

VS SYK

Stryker Corporation

$277.25 +0.70%

Bioventus Inc. Class A Common Stock (BVS) comes out ahead, leading on 5 of 9 compared factors.

Size & Scale

BVSSYK
Market Cap $881.82 million $105.60 billion
Revenue (TTM) $581.85 million $25.84 billion
Net Income (TTM) $61.48 million $3.73 billion

SYK leads on 3 of 3 size & scale factors.

Valuation

BVSSYK
P/E Ratio 17.29 28.73
Price / Book 3.18 4.40
Price / Sales 1.52 4.09

BVS leads on 3 of 3 valuation factors.

Profitability

BVSSYK
Net Margin 10.57% 14.43%
Return on Equity 22.16% 15.55%

BVS and SYK split the profitability factors evenly.

Dividend

BVSSYK
Dividend Yield — 1.27%
Payout Ratio — 36.48

BVS and SYK split the dividend factors evenly.

Risk & Sentiment

BVSSYK
Short Interest 0.78% 1.53%

BVS leads on 1 of 1 risk & sentiment factors.

Dig deeper: BVS overview, BVS financials, SYK overview, SYK financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.